The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells
Open accessAbstract
Chemokines dictate regional trafficking of functionally distinct T cell subsets. In rodents and humans, a unique subset of CD4+CD25+ cytotoxic T lymphocyte antigen (CTLA)-4+ regulatory T cells (Treg) has been proposed to control peripheral tolerance. However, the molecular basis of immune suppression and the trafficking properties of Treg cells are still unknown. Here, we determined the chemotactic response profile and chemokine receptor expression of human blood-borne CD4+CD25+ Treg cells. These Treg cells were found to vigorously respond to several inflammatory and lymphoid chemokines. Treg cells specifically express the chemokine receptors CCR4 and CCR8 and represent a major subset of circulating CD4+ T cells responding to the chemokines macrophage-derived chemokine (MDC)/CCL22, thymus and activation-regulated chemokine (TARC)/CCL17, I-309/CCL1, and to the virokine vMIP-I (ligands of CCR4 and CCR8). Blood-borne CD4+ T cells that migrate in response to CCL1 and CCL22 exhibit a reduced alloproliferative response, dependent on the increased frequency of Treg cells in the migrated population. Importantly, mature dendritic cells preferentially attract Treg cells among circulating CD4+ T cells, by secretion of CCR4 ligands CCL17 and CCL22. Overall, these results suggest that CCR4 and/or CCR8 may guide Treg cells to sites of antigen presentation in secondary lymphoid tissues and inflamed areas to attenuate T cell activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233 · cited 1×
“Recent studies demonstrated that CD4 CD25 CD45RB low memory T cells expressing cytotoxic T lymphocyte antigen (CTLA)-4 are regulatory T cells (Treg) that mediate tolerance to organ-specific self-antigens and can prevent autoimmunity and intestinal inflammation in mice (9, 10).”
BackgroundRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV
Moore, P. S., Boshoff, C., Weiss, R. A., & Chang, Y. (1996) · Science · doi:10.1126/science.274.5293.1739 · Cited by 904
Cited by
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Spranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., & Gajewski, T. F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006504 · Cited by 1,677
“Because previous work suggested that chemokines could contribute to T reg accumulation in tissues (28), we evaluated whether CD8 + effector T cells might produce any chemokines capable of T reg recruitment and whether chemokine-mediating trafficking participated in vivo.”
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
Natural regulatory T cells in infectious disease
Belkaid, Y., & Rouse, B. T. (2005) · Nature Immunology · doi:10.1038/ni1181 · Cited by 1,035
Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide
Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., & Demengeot, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021633 · Cited by 970
Jutel, M., Akdis, M., Budak, F., Aebischer‐Casaulta, C., Wrzyszcz, M., Blaser, K., & Akdis, C. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200322919 · Cited by 915
Chemokines: multiple levels of leukocyte migration control☆
Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.005 · Cited by 860
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
Cyster, J. G. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115628 · Cited by 856
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M., Onodera, M., Uchiyama, T., Fujii, S., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh165 · Cited by 801
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M., & Lipsky, P. E. (2006) · Blood · doi:10.1182/blood-2005-11-4567 · Cited by 781
Foxp3 occupancy and regulation of key target genes during T-cell stimulation
Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., Levine, S. S., Fraenkel, E., von Boehmer, H., & Young, R. A. (2007) · Nature · doi:10.1038/nature05478 · Cited by 724
Ishida, T., Joh, T., Uike, N., Yamamoto, K., Utsunomiya, A., Yoshida, S., Saburi, Y., Miyamoto, T., Takemoto, S., Suzushima, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.3472 · Cited by 657
Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts
Ochando, J. C., Homma, C., Yang, Y., Hidalgo, A., Garin, A., Tacke, F., Angeli, V., Li, Y., Boros, P., Ding, Y., et al. (2006) · Nature Immunology · doi:10.1038/ni1333 · Cited by 630
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Geginat, J., Lanzavecchia, A., & Sallusto, F. (2003) · Blood · doi:10.1182/blood-2002-11-3577 · Cited by 601
Valencia, X., Yarboro, C., Illei, G., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2579 · Cited by 594
CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin-Orozco, N., Kang, H. S., Ma, L., Panopoulos, A. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8391 · Cited by 551
TIGIT predominantly regulates the immune response via regulatory T cells
Kurtulus, S., Sakuishi, K., Ngiow, S.-F., Joller, N., Tan, D. J., Teng, M. W. L., Smyth, M. J., Kuchroo, V. K., & Anderson, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81187 · Cited by 551
RetractedDi Stasi, A., De Angelis, B., Rooney, C. M., Zhang, L., Mahendravada, A., Foster, A. E., Heslop, H. E., Brenner, M. K., Dotti, G., & Savoldo, B. (2009) · Blood · doi:10.1182/blood-2009-03-209650 · Cited by 533
Beyer, M., Kochanek, M., Darabi, K., Popov, A., Jensen, M., Endl, E., Knolle, P. A., Thomas, R. K., von Bergwelt-Baildon, M., Debey, S., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0642 · Cited by 492
Dieckmann, D., Bruett, C. H., Ploettner, H., Lutz, M. B., & Schuler, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020642 · Cited by 467
Zou, L., Barnett, B., Safah, H., LaRussa, V. F., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T. J., & Zou, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1987 · Cited by 456
Tan, M. C. B., Goedegebuure, P. S., Belt, B. A., Flaherty, B., Sankpal, N., Gillanders, W. E., Eberlein, T. J., Hsieh, C.-S., & Linehan, D. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1746 · Cited by 450
“For example, in their landmark study of Tregs in ovarian cancer, Curiel et al. (9) found that Tregs expressed CCR4 and that the tumor cells and tumor-associated macrophages released the CCR4 ligands, CCL17 and CCL22.”
BackgroundPrinciples of regulatory T cell function
Dikiy, S., & Rudensky, A. Y. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.004 · Cited by 445
Cao, D., Malmström, V., Baecher‐Allan, C., Hafler, D., Klareskog, L., & Trollmo, C. (2003) · European Journal of Immunology · doi:10.1002/immu.200390024 · Cited by 439
CCR4 and its ligands: from bench to bedside
Yoshie, O., & Matsushima, K. (2015) · International Immunology · doi:10.1093/intimm/dxu079 · Cited by 427
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7398 · Cited by 421
Yang, Z.-Z., Novak, A. J., Stenson, M. J., Witzig, T. E., & Ansell, S. M. (2006) · Blood · doi:10.1182/blood-2005-08-3376 · Cited by 420
Sather, B. D., Treuting, P., Perdue, N., Miazgowicz, M., Fontenot, J. D., Rudensky, A. Y., & Campbell, D. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070081 · Cited by 406
Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease
Silva, T. A., Garlet, G. P., Fukada, S. Y., Silva, J. S., & Cunha, F. Q. (2007) · Journal of Dental Research · doi:10.1177/154405910708600403 · Cited by 405
Cytokines and Chemokines in Mycobacterium tuberculosis Infection
Domingo-Gonzalez, R., Prince, O., Cooper, A., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 404
Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Vanini, V., Romagnani, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1320 · Cited by 383
Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes
Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., & Romagnani, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020110 · Cited by 379
Faustino, L., Mucida, D., Keller, A. C., Demengeot, J., Bortoluci, K., Sardinha, L. R., Carla Takenaka, M., Basso, A. S., Faria, A. M. C., & Russo, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/721817 · Cited by 376
Korbecki, J., Grochans, S., Gutowska, I., Barczak, K., & Baranowska-Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207619 · Cited by 373
Szanya, V., Ermann, J., Taylor, C., Holness, C., & Fathman, C. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2461 · Cited by 373
Lee, I., Wang, L., Wells, A. D., Dorf, M. E., Ozkaynak, E., & Hancock, W. W. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041709 · Cited by 371
Chieppa, M., Bianchi, G., Doni, A., Del Prete, A., Sironi, M., Laskarin, G., Monti, P., Piemonti, L., Biondi, A., Mantovani, A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4552 · Cited by 368
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A., & Sallusto, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050085 · Cited by 361
Lloyd, C. M., & Hawrylowicz, C. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.007 · Cited by 356
Intricacies of TGF-β signaling in Treg and Th17 cell biology
Wang, J., Zhao, X., & Wan, Y. Y. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01036-7 · Cited by 356
Penna, G., Amuchastegui, S., Giarratana, N., Daniel, K. C., Vulcano, M., Sozzani, S., & Adorini, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.145 · Cited by 355
Yamamoto, K., Utsunomiya, A., Tobinai, K., Tsukasaki, K., Uike, N., Uozumi, K., Yamaguchi, K., Yamada, Y., Hanada, S., Tamura, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3575 · Cited by 354
de Jager, W., Hoppenreijs, E. P. A. H., Wulffraat, N. M., Wedderburn, L. R., Kuis, W., & Prakken, B. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061853 · Cited by 347
Regulatory T-cell compartmentalization and trafficking
Wei, S., Kryczek, I., & Zou, W. (2006) · Blood · doi:10.1182/blood-2006-01-0177 · Cited by 346
Nistala, K., Moncrieffe, H., Newton, K. R., Varsani, H., Hunter, P., & Wedderburn, L. R. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23291 · Cited by 334
A peripheral circulating compartment of natural naive CD4 Tregs
Valmori, D., Merlo, A., Souleimanian, N. E., Hesdorffer, C. S., & Ayyoub, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23963 · Cited by 319
Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis
Monneret, G., Debard, A.-L., Venet, F., Bohe, J., Hequet, O., Bienvenu, J., & Lepape, A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000069345.78884.0f · Cited by 317
A Role for CD103 in the Retention of CD4+CD25+ Treg and Control of Leishmania major Infection
Suffia, I., Reckling, S. K., Salay, G., & Belkaid, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5444 · Cited by 316
Qu, C., Edwards, E. W., Tacke, F., Angeli, V., Llodrá, J., Sanchez-Schmitz, G., Garin, A., Haque, N. S., Peters, W., van Rooijen, N., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032152 · Cited by 316
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
Kleinewietfeld, M., Puentes, F., Borsellino, G., Battistini, L., Rötzschke, O., & Falk, K. (2005) · Blood · doi:10.1182/blood-2004-07-2505 · Cited by 312
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Olkhanud, P. B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R. L., Deng, J., Xu, M., Briest, S., & Biragyn, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4619 · Cited by 312
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells
Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W., & Unutmaz, D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020198 · Cited by 301
Mendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D., & Belkaid, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040298 · Cited by 296
Ishida, T., Ishii, T., Inagaki, A., Yano, H., Komatsu, H., Iida, S., Inagaki, H., & Ueda, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0261 · Cited by 291
Hirahara, K., Liu, L., Clark, R. A., Yamanaka, K.-I., Fuhlbrigge, R. C., & Kupper, T. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4488 · Cited by 291
Lim, H. W., Hillsamer, P., & Kim, C. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22325 · Cited by 288
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Heller, E. A., Liu, E., Tager, A. M., Yuan, Q., Lin, A. Y., Ahluwalia, N., Jones, K., Koehn, S. L., Lok, V. M., Aikawa, E., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.605121 · Cited by 283
Hori, S., Carvalho, T. L., & Demengeot, J. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1282::aid-immu1282>3.0.co;2-# · Cited by 282
Louis, S., Braudeau, C., Giral, M., Dupont, A., Moizant, F., Robillard, N., Moreau, A., Soulillou, J.-P., & Brouard, S. (2006) · Transplantation · doi:10.1097/01.tp.0000203166.44968.86 · Cited by 277
Takahashi, R., Kano, Y., Yamazaki, Y., Kimishima, M., Mizukawa, Y., & Shiohara, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804002 · Cited by 276
Weber, C., Meiler, S., Döring, Y., Koch, M., Drechsler, M., Megens, R. T. A., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44925 · Cited by 273
Rapp, M., Wintergerst, M. W. M., Kunz, W. G., Vetter, V. K., Knott, M. M. L., Lisowski, D., Haubner, S., Moder, S., Thaler, R., Eiber, S., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20170277 · Cited by 271
Jacobsen, E. A., Ochkur, S. I., Pero, R. S., Taranova, A. G., Protheroe, C. A., Colbert, D. C., Lee, N. A., & Lee, J. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071840 · Cited by 263
Inhibition of Human CD4+CD25+high Regulatory T Cell Function
Baecher-Allan, C., Viglietta, V., & Hafler, D. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6210 · Cited by 262
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Muller, A. J., & Scherle, P. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1929 · Cited by 262
Lim, H. W., Hillsamer, P., & Kim, C. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422325 · Cited by 260
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Gonzalez–Rey, E., Chorny, A., & Delgado, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.041 · Cited by 259
Beissert, S., Schwarz, A., & Schwarz, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700004 · Cited by 255
Regulatory T cells in virus infections
Rouse, B. T., Sarangi, P. P., & Suvas, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00412.x · Cited by 255
Mishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S. M., Granot, Z., & Fridlender, Z. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28770 · Cited by 253
Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells
Penna, G., Vulcano, M., Sozzani, S., & Adorini, L. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00755-3 · Cited by 252
Széles, L., Keresztes, G., Töröcsik, D., Balajthy, Z., Krenács, L., Póliska, S., Steinmeyer, A., Zuegel, U., Pruenster, M., Rot, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803345 · Cited by 234
Häringer, B., Lozza, L., Steckel, B., & Geginat, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082238 · Cited by 150
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications
Rutella, S., & Lemoli, R. M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.04.015 · Cited by 147
Tanchot, C., Terme, M., Pere, H., Tran, T., Benhamouda, N., Strioga, M., Banissi, C., Galluzzi, L., Kroemer, G., & Tartour, E. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0122-y · Cited by 138
Cuadrado, E., van den Biggelaar, M., de Kivit, S., Chen, Y.-Y., Slot, M., Doubal, I., Meijer, A., van Lier, R. A. W., Borst, J., & Amsen, D. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.008 · Cited by 132
Mikhak, Z., Fukui, M., Farsidjani, A., Medoff, B. D., Tager, A. M., & Luster, A. D. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.049 · Cited by 127
Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity
Yano, H., Andrews, L. P., Workman, C. J., & Vignali, D. A. A. (2019) · Immunology · doi:10.1111/imm.13067 · Cited by 116
Nadph oxidase 1 in liver macrophages promotes inflammation and tumor development in mice
Liang, S., Ma, H.-Y., Zhong, Z., Dhar, D., Liu, X., Xu, J., Koyama, Y., Nishio, T., Karin, D., Karin, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.019 · Cited by 92
Statins induce regulatory T cell recruitment via a CCL1 dependent pathway.
Mira, E., León, B., Barber, D. F., Jiménez-Baranda, S., Goya, I., Almonacid, L., Márquez, G., Zaballos, A., Martínez-A., C., Stein, J. V., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3524 · Cited by 88
Chemokine receptors in allergic diseases
Castan, L., Magnan, A., & Bouchaud, G. (2017) · Allergy · doi:10.1111/all.13089 · Cited by 80
Regulatory T Cell-Mediated Tissue Repair
Hong, J., & Kim, B.-S. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-0445-3_14 · Cited by 16
Edward, J. A., Sanyal, M., Le, W., Soudry, E., Ramakrishnan, V. R., Bravo, D. T., Nguyen, A. L., Zarabanda, D., Kingdom, T. T., Hwang, P. H., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.02.002 · Cited by 13
An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis
Talvio, K., Wagner, V. A., Minkeviciene, R., Kirkwood, J. S., Kulinich, A. O., Umemori, J., Bhatia, A., Hur, M., Käkelä, R., Ethell, I. M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05147-9 · Cited by 8
Metadata
- Authors
- Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., & D'Ambrosio, D.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-09-17
- Volume
- 194
- Issue
- 6
- Pages
- 847-854
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2110714188
- Cited by
- 914
- References
- 30
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.